Targeted next-generation sequencing makes new molecular diagnoses and expands genotype–phenotype relationship in Ehlers–Danlos syndrome
Author(s) -
Ruwan Weerakkody,
Jana Vandrovcová,
Christina Kaidou,
Michael Mueller,
Piyush Gampawar,
Yousef Ibrahim,
Penny J. Norsworthy,
Jennifer Biggs,
Abdulshakur Abdullah,
David Ross,
Holly A. Black,
David Ferguson,
Nicholas Cheshire,
Hanadi Kazkaz,
Rodney Grahame,
Neeti Ghali,
Anthony Vandersteen,
F M Pope,
Timothy J. Aitman
Publication year - 2016
Publication title -
genetics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.509
H-Index - 128
eISSN - 1530-0366
pISSN - 1098-3600
DOI - 10.1038/gim.2016.14
Subject(s) - ehlers–danlos syndrome , sanger sequencing , dna sequencing , genetics , genetic testing , biology , genotype , gene , phenotype , cohort , exome sequencing , medicine , bioinformatics , pathology
Ehlers-Danlos syndrome (EDS) comprises a group of overlapping hereditary disorders of connective tissue with significant morbidity and mortality, including major vascular complications. We sought to identify the diagnostic utility of a next-generation sequencing (NGS) panel in a mixed EDS cohort.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom